Boston-based Dana-Farber Cancer Institute has named Kathleen Keavany senior vice president of ambulatory care. In the newly created role, Ms. Keavany will oversee all adult ambulatory services and work alongside leadership at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center for…
The Latest
Miami-based Baptist Health Herbert Wertheim Cancer Institute has named Alia Abdulla, DO, chief of breast surgical oncology in Plantation, Fla. Dr. Abdulla serves as a clinical assistant professor of surgery at Miami-based Florida International University and Fort Lauderdale, Fla.-based Nova…
An androgen receptor inhibitor was found to improve rates of metastasis-free survival among prostate cancer patients when combined with androgen deprivation therapy, according to a study published May 31 in The New England Journal of Medicine. The study was led…
An unexpected bill can undo an otherwise positive care experience. With bad debt and charity care expenses up 17% year over year in March 2026, and nearly half of American adults reporting difficulty affording care, the financial side of healthcare…
Presented by:
Seattle-based Fred Hutch Cancer Center has appointed Nida Shekhani executive vice president and chief strategy and clinical growth officer. Ms. Shekhani will step into the role July 1, according to a June 3 LinkedIn post from the cancer center. She…
New York City-based Memorial Sloan Kettering Cancer Center has appointed Martin Weiser, MD, chair of the department of surgery. Dr. Weiser joined Memorial Sloan Kettering 25 years ago and has served as acting department chair for the past 10 months,…
The American Cancer Society added Guardant Health’s Shield blood test to its updated colorectal cancer screening guidelines, published May 27. The Palo Alto, Calif.-based precision oncology company said the ACS now recommends Shield for patients who decline or have not…
In April, the FDA debuted a real-time clinical trial model that will allow the agency to monitor safety signals as the trial is being conducted. The first trials were launched in partnership with Houston-based University of Texas MD Anderson Cancer…
Researchers at the University of California, Irvine, have found that some antibody-drug conjugates, an emerging class of targeted cancer therapies, were associated with serious infection-related complications, including hospitalization and intensive care admissions. The study analyzed treatment data from 3,511 patients…
Most pharmacy leaders track vacancies and recruiting spend. Far fewer see the full cost of turnover as it spreads into capacity, resilience and the ability to execute strategic priorities. This live webinar will examine what leaders are missing about pharmacy…
Jun 24, 2026 1:00 PM - 2:00 PM CDT
Presenters:
- Tina Moan, PharmD
- Julie Lanza CPhT-Adv, CSPT, CPTEd, FMSHP